A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma

Dataset: We provide a dataset on lymph node level (LNL) involvement in 287 patients with newly diagnosed oropharyngeal squamous cell carcinoma (OPSCC). For each patient, ipsilateral and contralateral LNL involvement for levels I to VII is reported together with clinicopathological factors including TNM-stage, primary tumor subsite, tumor lateralization, HPV status, sex, age, smoking status, and primary treatment. LNL involvement was assessed individually based on available diagnostic modalities (PET, MRI, CT, fine needle aspiration) by reviewing pathology and radiology reports together with the radiological images. The data is shared as a CSV-table with rows of patients and columns of patient/tumor-specific information and the involvement of individual LNL based on the respective diagnostic modalities. Reuse potential: Patterns of lymphatic progression have never been reported on a patient-individual basis in as much detail as provided in this dataset. The data can be used to build quantitative models for lymphatic tumor progression to estimate the probability of occult metastases in LNLs. This may in turn allow for further personalization of the elective clinical target volume definition in radiotherapy and the extent of neck dissection for surgically treated patients. The data can be pooled with other data to build large multi-institutional datasets on lymphatic metastatic progression in the future. Co-submission: This paper supports the original scientific article by Roman Ludwig, Jean-Marc Hoffmann, Bertrand Pouy-mayou, Gregoire Morand, Martina Broglie Dappen, Matthias Guckenberger, Vincent Gregoire, Panagiotis Balermpas, Jan Unkelbach, Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface, Radiotherapy & Oncology [1] (C) 2022 Published by Elsevier Inc.

Automated summary

The dataset provides detailed information on lymph node involvement in patients with oropharyngeal squamous cell carcinoma. It can be used to build quantitative models for predicting lymphatic metastasis and personalize the clinical target volume definition and neck dissection range in radiation therapy and surgical treatment.